Nabriva Therapeutics
NBRV
$1.42
Share price
0.00%
Change (1 day)
-71.20%
Change (1 year)
Categories
Operating Margin for Nabriva Therapeutics (NBRV)
Operating Margin as of May 2024 (TTM): -155.92%
According to Nabriva Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -155.92%. At the end of 2021 the company had an Operating Margin of -179.89%.
Operating Margin history for Nabriva Therapeutics from 2019 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -179.89% | -92.57% |
| 2020 | -2,421.26% | 126.94% |
| 2019 | -1,066.89% | -39.56% |
| 2018 | -1,765.09% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.